Contact us

White Papers & Resources

Instructions for use

The Galaxy System™ and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures.

This information is for Galaxy System customers only. Please do not share. To access the Galaxy System™ Instructions For Use click the link below.

Download PDF Software version 1.0.1.0 

Download PDF Software version 1.0.1.0 

Download PDF Software version 1.0.2.0

Download PDF Software version 1.0.2.0

Lung_Centered_small

“The ability to be able to toss the scope at the end of each case reduces the burden on my team and improves turnover times.”

- Krish Bhadra, MD

building a robotic lung biopsy program

Building a Robotic Lung Biopsy Program

Detection, diagnosis and treatment of early-stage lung cancer saves lives. Learn how your institution can increase procedural volume and revenue, avoid significant capital expenditure to correct for CT-to-body divergence, reduce the risk of cross-contamination and avoid the hidden costs of reprocessing bronchoscopes with the Galaxy System™, the next generation, image-integrated robotic-assisted bronchoscopy (iiRAB) solution.

 

disposable vs reusable bronchoscopes

Comparison of Disposable vs. Reusable Robotic Bronchoscopes

Single-use disposable bronchoscopes offer several advantages over reusable bronchoscopes. To learn more about the hidden costs of reprocessing bronchoscopes, the risk of cross-contamination and its associated treatment costs as well as the environmental impact of reprocessing bronchoscopes, click on the button below.

 

NoahMedical_Impact_of_Early_Diagnosis_Dr_Kovacs_020224_VFINAL-1

Impact of Early Diagnosis in Lung Cancer

Early detection of lung cancer offers several clinical and economic benefits. A combination of patient education, multi-disciplinary integrated lung nodule programs and the use of advanced imaging-integrated robotic-assisted biopsy technologies can help identify, diagnose and treat lung cancer at an earlier stage and improve clinical outcomes for patients while relieving some of the economic burden associated with lung cancer.